What's the Best Way to Invest in Genetics Stocks?
The gene editing space is full of exciting investment opportunities, but it isn't exactly a low-risk industry. In this Fool Live video clip, recorded on May 24, Fool.com contributor Brian Orelli, PhD, along with Healthcare Bureau Chief Corinne Cardina and Chief Growth Officer Anand Chokkavelu discuss how investors should best approach it. Anand Chokkavelu: Then as we look to fit this in part of a larger portfolio, assuming the folks are more like me where it's not your focus but you want to have but you've liked the idea of the technology.